MedTrace Logo

The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular Dystrophy

NCT07092540 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2026-05-04

No results posted yet for this study

Summary

The aim of the BABY DUCHENNE study is to evaluate the natural history and characterize the early clinical outcomes in very young children (0-3 years) with Duchenne muscular dystrophy (DMD) identified by newborn screening programs.

Conditions

  • Duchenne Muscular Dystrophy (DMD)

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • University of Rochester

    lead OTHER

Eligibility

Min Age
0 Days
Max Age
3 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-30
Primary Completion
2029-08-31
Completion
2029-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07092540 on ClinicalTrials.gov